174 related articles for article (PubMed ID: 17649714)
1. [The therapeutic efficacy for limb ischemia by transplantation of mobilized peripheral blood cells before and after CD34+ cell depletion].
Zhou B; Li S; Gu DS; Wu KH; Liu PX; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2007 Mar; 28(3):194-8. PubMed ID: 17649714
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells.
Li S; Zhou B; Han ZC
Thromb Haemost; 2006 Feb; 95(2):301-11. PubMed ID: 16493493
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of neovascularization with mobilized blood cells transplantaion: supply of angioblasts and angiogenic cytokines.
Zhou B; Liu PX; Lan HF; Fang ZH; Han ZB; Ren H; Poon MC; Han ZC
J Cell Biochem; 2007 Sep; 102(1):183-95. PubMed ID: 17390342
[TBL] [Abstract][Full Text] [Related]
4. [Neovascularization potential of mobilized peripheral mononuclear cells from diabetes patients].
Zhou B; Gu DS; Liu PX; Zheng CL; Dong CL; Du WT; Wu KH; Han ZC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Apr; 29(2):262-7. PubMed ID: 17536281
[TBL] [Abstract][Full Text] [Related]
5. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia.
Cho SW; Moon SH; Lee SH; Kang SW; Kim J; Lim JM; Kim HS; Kim BS; Chung HM
Circulation; 2007 Nov; 116(21):2409-19. PubMed ID: 17984381
[TBL] [Abstract][Full Text] [Related]
6. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.
Iwase T; Nagaya N; Fujii T; Itoh T; Murakami S; Matsumoto T; Kangawa K; Kitamura S
Cardiovasc Res; 2005 Jun; 66(3):543-51. PubMed ID: 15914119
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis of bone marrow mononuclear cells (MNCs) and peripheral blood MNCs: transplantation for ischemic hindlimb.
Zhang H; Zhang N; Li M; Feng H; Jin W; Zhao H; Chen X; Tian L
Ann Vasc Surg; 2008 Mar; 22(2):238-47. PubMed ID: 18083329
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic neovascularization with autologous bone marrow CD34+ cells transplantation in hindlimb ischemia].
Zhang HK; Zhang N; Wu LH; Jin W; Li M; Feng H; Zhao HG; Chen XD; Yang CH
Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(19):1275-8. PubMed ID: 16271229
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats.
Hasegawa T; Kosaki A; Shimizu K; Matsubara H; Mori Y; Masaki H; Toyoda N; Inoue-Shibata M; Nishikawa M; Iwasaka T
Exp Neurol; 2006 Jun; 199(2):274-80. PubMed ID: 16337192
[TBL] [Abstract][Full Text] [Related]
10. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.
Iwasaki H; Kawamoto A; Ishikawa M; Oyamada A; Nakamori S; Nishimura H; Sadamoto K; Horii M; Matsumoto T; Murasawa S; Shibata T; Suehiro S; Asahara T
Circulation; 2006 Mar; 113(10):1311-25. PubMed ID: 16534028
[TBL] [Abstract][Full Text] [Related]
11. CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases.
Lee JH; Lee SH; Yoo SY; Asahara T; Kwon SM
Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1622-34. PubMed ID: 23640491
[TBL] [Abstract][Full Text] [Related]
12. Circulating human CD34+ progenitor cells modulate neovascularization and inflammation in a nude mouse model.
van der Strate BW; Popa ER; Schipper M; Brouwer LA; Hendriks M; Harmsen MC; van Luyn MJ
J Mol Cell Cardiol; 2007 Jun; 42(6):1086-97. PubMed ID: 17490680
[TBL] [Abstract][Full Text] [Related]
13. Combined growth factors enhanced angiogenic potential of cord blood-derived mononuclear cells transplanted to ischemic limbs.
Kim MH; Zhang HZ; Kim SW
J Mol Cell Cardiol; 2011 Nov; 51(5):702-12. PubMed ID: 21782826
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration.
Kwon SM; Suzuki T; Kawamoto A; Ii M; Eguchi M; Akimaru H; Wada M; Matsumoto T; Masuda H; Nakagawa Y; Nishimura H; Kawai K; Takaki S; Asahara T
Circ Res; 2009 Apr; 104(8):969-77. PubMed ID: 19325148
[TBL] [Abstract][Full Text] [Related]
15. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells.
Kawamoto A; Iwasaki H; Kusano K; Murayama T; Oyamada A; Silver M; Hulbert C; Gavin M; Hanley A; Ma H; Kearney M; Zak V; Asahara T; Losordo DW
Circulation; 2006 Nov; 114(20):2163-9. PubMed ID: 17075009
[TBL] [Abstract][Full Text] [Related]
16. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the ischemic hind limb of the mouse.
Bir SC; Esaki J; Marui A; Yamahara K; Tsubota H; Ikeda T; Sakata R
J Vasc Surg; 2009 Oct; 50(4):870-879.e2. PubMed ID: 19679427
[TBL] [Abstract][Full Text] [Related]
17. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
18. Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues.
Pesce M; Orlandi A; Iachininoto MG; Straino S; Torella AR; Rizzuti V; Pompilio G; Bonanno G; Scambia G; Capogrossi MC
Circ Res; 2003 Sep; 93(5):e51-62. PubMed ID: 12919944
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia.
Kudo FA; Nishibe T; Nishibe M; Yasuda K
Int Angiol; 2003 Dec; 22(4):344-8. PubMed ID: 15153817
[TBL] [Abstract][Full Text] [Related]
20. The cyclooxygenase-2 selective inhibitor, etodolac, but not aspirin reduces neovascularization in a murine ischemic hind limb model.
Tanaka K; Yamamoto Y; Tsujimoto S; Uozumi N; Kita Y; Yoshida A; Shimizu T; Hisatome I
Eur J Pharmacol; 2010 Feb; 627(1-3):223-8. PubMed ID: 19879866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
